DM
Dr. Maya Ellison
Founder & CEO
Company
Company
Pathelium is building the world's leading epithelial intelligence platform to help transform oncology from late recognition to earlier biological understanding.
What we do
We believe cancer research has spent decades looking harder at the mass, the lesion, the late-stage signal, while giving too little strategic focus to the tissue systems where transformation starts. Carcinomas arise in epithelial tissue and include many of the cancers that shape the global cancer burden, including breast, lung, bowel, prostate, and many skin cancers.
So we asked a different question.
What if the next frontier in oncology is not only treating tumors better, but understanding the protective tissue that fails before the tumor is fully seen?
Our Story
Pathelium began with a focused observation: the tissue systems that protect the body are also where many cancers first begin. From that starting point, the company set out to build around epithelial biology rather than only around late-stage disease signals.
That decision shaped the company's direction from the beginning. Pathelium has grown its thesis around pathology, machine learning, and disciplined product development so the earliest tissue-level changes can be studied with greater clarity.
Today, Pathelium is building the platform, scientific framing, and research infrastructure needed to turn that thesis into a serious long-term company.
Our Team
Pathelium is a multidisciplinary team spanning oncology, pathology, machine learning, engineering, and product design.
DO
Daniel Okoro
Chief Scientific Officer
DN
Dr. Nikhil Saran
Head of Pathology Research
AY
Amina Yusuf
Director of Machine Learning
LP
Lena Park
VP, Platform Engineering
CB
Clara Bennett
Product Design Lead
MC
Marcus Chen
Head of Data Partnerships
SA
Sofia Alvarez
Operations & Strategy Lead
Our Values
The company is being built with a few principles kept deliberately close to the work.
Scientific rigor
We let biology, pathology context, and evidence set the scope for what we build.
Focused execution
We concentrate on epithelial intelligence instead of spreading across adjacent categories.
Product discipline
We translate complex research into tools that are credible, legible, and useful.
Long-term conviction
We are building patiently around an important scientific thesis rather than short-term noise.
See the platform behind the thesis
Epithelia AI is the core product expression of Pathelium's scientific direction.